Literature DB >> 20081804

Expression of sphingosine-1-phosphate receptor 1 in mantle cell lymphoma.

Hirotake Nishimura1, Takashi Akiyama, Yasumasa Monobe, Kiminori Matsubara, Yasuyuki Igarashi, Masafumi Abe, Takashi Sugihara, Yoshito Sadahira.   

Abstract

The distribution and pathological significance of sphingosine-1-phosphate receptor 1 expression are still unclear. In this study, we evaluated sphingosine-1-phosphate receptor 1's suitability as a diagnostic marker for malignant lymphoma by immunostaining formalin-fixed paraffin-embedded sections using a well-defined commercial anti-sphingosine-1-phosphate receptor 1 antibody. Sphingosine-1-phosphate receptor 1 was strongly expressed on the surface of small lymphocytes forming primary lymphoid follicles and in the mantle zone of secondary lymphoid follicles. Microarray-based immunohistochemistry with tissue samples from 85 lymphoid malignancy cases demonstrated that sphingosine-1-phosphate receptor 1 was expressed on the surface of mantle cell lymphoma cells. Strong expression was observed in all classical mantle cell lymphoma cases involving the lymph node (19 out of 19), gastrointestinal tract (10 out of 10), bone marrow (9 out of 9), and orbita (1 out of 1). Good results were obtained even in sections where cyclin D1 signals were lost because of over-fixation and/or decalcification. One aggressive variant of mantle cell lymphoma displayed a weaker membranous staining than classical mantle cell lymphoma in the lymph node and bone marrow. In a cyclin D1-negative mantle cell lymphoma of the orbita, no conclusive result was obtained. No cases of follicular lymphoma, marginal zone lymphoma, B lymphoblastic leukemia/lymphoma, or Burkitt's lymphoma showed any significant expression, whereas 2 out of 6 chronic lymphocytic leukemia/small lymphocytic lymphomas in bone marrow, 1 out of 3 lymphoplasmacytic lymphomas in the lymph node, and 2 out of 37 diffuse large B-cell lymphomas exhibited staining. A quantitative reverse transcription polymerase chain reaction-based analysis of mantle cell lymphoma lines revealed the sphingosine-1-phosphate receptor 1 mRNA expression level to be well correlated with the results of immunocytochemistry, flow cytometry, and western blotting. Thus, sphingosine-1-phosphate receptor 1 immunohistochemistry may be useful in the histological diagnosis of mantle cell lymphoma with formalin-fixed and paraffin-embedded sections. The antigen may be particularly valuable in cases where cyclin D1 immunostaining is not successful.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20081804     DOI: 10.1038/modpathol.2009.194

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  15 in total

1.  New developments in the pathology of malignant lymphoma: a review of the literature published from October 2009 to January 2010.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2010-06-02       Impact factor: 0.196

Review 2.  The role of G protein-coupled receptors in lymphoid malignancies.

Authors:  Adrienne Nugent; Richard L Proia
Journal:  Cell Signal       Date:  2017-08-09       Impact factor: 4.315

Review 3.  Sphingolipid signaling and hematopoietic malignancies: to the rheostat and beyond.

Authors:  Kenneth C Loh; Dianna Baldwin; Julie D Saba
Journal:  Anticancer Agents Med Chem       Date:  2011-11       Impact factor: 2.505

Review 4.  Targeting sphingosine-1-phosphate in hematologic malignancies.

Authors:  Christina E Stevenson; Kazuaki Takabe; Masayuki Nagahashi; Sheldon Milstien; Sarah Spiegel
Journal:  Anticancer Agents Med Chem       Date:  2011-11       Impact factor: 2.505

5.  Clinical and functional impact of recurrent S1PR1 mutations in mantle cell lymphoma.

Authors:  Agata M Wasik; Chenglin Wu; Larry Mansouri; Richard Rosenquist; Qiang Pan-Hammarström; Birgitta Sander
Journal:  Blood Adv       Date:  2018-03-27

6.  Cellular localization of sphingosine-1-phosphate receptor 1 expression in the human central nervous system.

Authors:  Hirotake Nishimura; Takashi Akiyama; Isao Irei; Shuji Hamazaki; Yoshito Sadahira
Journal:  J Histochem Cytochem       Date:  2010-06-21       Impact factor: 2.479

Review 7.  Sphingolipids and Lymphomas: A Double-Edged Sword.

Authors:  Alfredo Pherez-Farah; Rosa Del Carmen López-Sánchez; Luis Mario Villela-Martínez; Rocío Ortiz-López; Brady E Beltrán; José Ascención Hernández-Hernández
Journal:  Cancers (Basel)       Date:  2022-04-19       Impact factor: 6.575

Review 8.  Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies.

Authors:  C Evangelisti; C Evangelisti; F Buontempo; A Lonetti; E Orsini; F Chiarini; J T Barata; S Pyne; N J Pyne; A M Martelli
Journal:  Leukemia       Date:  2016-07-27       Impact factor: 11.528

9.  Evaluation of S1PR1, pSTAT3, S1PR2, FOXP1 Expression in Aggressive, Mature B Cell Lymphomas.

Authors:  Mustafa Al-Kawaaz; Teresa Sanchez; Michael J Kluk
Journal:  J Hematop       Date:  2019-04-27       Impact factor: 0.196

10.  Sphingosine-1-phosphate receptor 1 in classical Hodgkin lymphoma: assessment of expression and role in cell migration.

Authors:  Michael J Kluk; Kieran P Ryan; Bonnie Wang; Guoqi Zhang; Scott J Rodig; Teresa Sanchez
Journal:  Lab Invest       Date:  2013-02-18       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.